<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250907067159N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-07</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Supportive Counseling With and Without Auriculotherapy on Postpartum Stress and Anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effects of Supportive Counseling With and Without Auriculotherapy on Postpartum Stress and Anxiety</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>78</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87095</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization will be performed using a stratified block randomization method.
The unit of randomization is the individual mother. Stratification will be based on type of delivery (vaginal/cesarean) and parity (primiparous/multiparous) to ensure balanced baseline characteristics.
The random allocation sequence will be generated using variable block sizes of 3 and 6 by an independent person through Random Allocation Software.
For allocation concealment, the group codes will be placed in opaque, sealed, and sequentially numbered envelopes, opened in order by a person not involved in the study.
Participants will be randomly assigned to one of three groups: supportive counseling, supportive counseling with auricular acupressure, or routine postpartum care.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Postpartum Anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In one of the intervention groups, supportive counseling will be conducted in person over three sessions on days 10–15, 15–22, and 30 postpartum, each lasting 30–45 minutes. The content of the counseling sessions, based on the supportive counseling protocol, is as follows:Session 1 (10–15 days postpartum):This session includes an introduction, taking a medical and psychological history, discussing the rules, conditions, and goals of the counseling process, and encouraging the mother to express any questions and concerns that cause stress and anxiety during the postpartum period. The session also focuses on exploring the mother’s emotional and psychological reactions to her new situation. The counselor looks for signs of functional disruption, stress symptoms, and maladaptive coping strategies in order to identify the mother’s adaptive strengths and weaknesses. This allows the counselor to explain appropriate coping methods (such as relaxation techniques, seeking and mobilizing social support, and improving communication skills—particularly with the spouse).Additionally, the session provides education on adequate breast milk supply, reasons for infant crying and refusal to breastfeed, neonatal danger signs, vomiting and aspiration, neonatal jaundice, maternal nutrition during breastfeeding and strategies to increase milk production, breast problems, constipation, postpartum bleeding, back pain, episiotomy wound care, pain management, and umbilical cord care.Session 2 (15–22 days postpartum):In this session, the mother’s physical and psychological experiences are reviewed, and signs of stress and anxiety are assessed. Relaxation techniques and coping skills are revisited, with an emphasis on the role of social support. Practical, individualized strategies for managing stress and anxiety are also provided.Session 3 (30 days postpartum):At this stage, the mother’s progress in using psychological coping skills is evaluated. Questions are addressed, and additional recommendations are offered. Intervention 2: Intervention group: In the other intervention group, supportive counseling combined with auriculotherapy will be conducted in person over three sessions on days 10–15, 15–22, and 30 postpartum, each lasting 30–45 minutes. The content of the counseling sessions is identical to that of the first intervention group.Session 1:Alongside supportive counseling, Vaccaria seeds will be applied to specific points on the auricle. The selected points include Shen Men, Anxiety, and Mammary Gland 1 &amp; 2 on the left ear, and Thalamic, Master Shoulder, Cerebral, and Lung 1 &amp; 2 on the right ear. The mother will be instructed on how to stimulate these points: she should gently apply pressure to each point for one minute, 5–6 times a day.Session 2:In addition to supportive counseling, the auriculotherapy seeds will be replaced, and the same points will be stimulated again.Session 3:During this session, the auriculotherapy seeds will once again be replaced and the same points stimulated. The counselor will also assess whether the mother has been correctly stimulating the ear points and evaluate the extent of their effectiveness. Intervention 3: Control group: In this study, the control group will receive only the usual care after delivery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is It is confidential.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Omranian Esfahani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati, Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5313644351</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>z.omranian@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Roghaiyeh Nourizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati St., Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>nourizadehr@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women aged 18–49 years
Willingness to breastfeed their infants
Residence in Tabriz
Singleton delivery
Mothers with term neonates weighing 2,500–4,000 grams
Mothers with a stress score higher than 14–26  and a moderate anxiety score of 32–50 (above the mean score according to the Angoff method)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Mothers with hospitalized neonates
Presence of systemic or chronic diseases or conditions exacerbated during pregnancy or postpartum, including gestational or overt diabetes, hypertensive disorders, cardiac diseases, or inability to care for the newborn
Experience of major adverse life events during the past three months, such as death of first-degree relatives or divorce
History of psychiatric disorders or use of antidepressant or antipsychotic medications, based on the mother’s self-report
Unplanned pregnancies, fetal abnormalities, hypothyroidism, or neonatal death
Mothers with breast anomalies, history of breast surgery, or contraindications to breastfeeding, including: • Women under chemotherapy. • Women with HIV infection or untreated active tuberculosis. • Women using radioactive drugs, antimetabolites, or contraindicated medications during lactation, such as methotrexate, mercaptopurine, hydroxyurea, tamoxifen, bromocriptine, lithium, phenindione, phencyclidine, cyclophosphamide, and doxorubicin, as well as illicit drug use
The Edinburgs Depression Score of 13 or higher</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other anxiety disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In one of the intervention groups, supportive counseling will be conducted in person over three sessions on days 10–15, 15–22, and 30 postpartum, each lasting 30–45 minutes. The content of the counseling sessions, based on the supportive counseling protocol, is as follows:Session 1 (10–15 days postpartum):This session includes an introduction, taking a medical and psychological history, discussing the rules, conditions, and goals of the counseling process, and encouraging the mother to express any questions and concerns that cause stress and anxiety during the postpartum period. The session also focuses on exploring the mother’s emotional and psychological reactions to her new situation. The counselor looks for signs of functional disruption, stress symptoms, and maladaptive coping strategies in order to identify the mother’s adaptive strengths and weaknesses. This allows the counselor to explain appropriate coping methods (such as relaxation techniques, seeking and mobilizing social support, and improving communication skills—particularly with the spouse).Additionally, the session provides education on adequate breast milk supply, reasons for infant crying and refusal to breastfeed, neonatal danger signs, vomiting and aspiration, neonatal jaundice, maternal nutrition during breastfeeding and strategies to increase milk production, breast problems, constipation, postpartum bleeding, back pain, episiotomy wound care, pain management, and umbilical cord care.Session 2 (15–22 days postpartum):In this session, the mother’s physical and psychological experiences are reviewed, and signs of stress and anxiety are assessed. Relaxation techniques and coping skills are revisited, with an emphasis on the role of social support. Practical, individualized strategies for managing stress and anxiety are also provided.Session 3 (30 days postpartum):At this stage, the mother’s progress in using psychological coping skills is evaluated. Questions are addressed, and additional recommendations are offered.</i_keyword>
      <i_keyword>Intervention group: In the other intervention group, supportive counseling combined with auriculotherapy will be conducted in person over three sessions on days 10–15, 15–22, and 30 postpartum, each lasting 30–45 minutes. The content of the counseling sessions is identical to that of the first intervention group.Session 1:Alongside supportive counseling, Vaccaria seeds will be applied to specific points on the auricle. The selected points include Shen Men, Anxiety, and Mammary Gland 1 &amp; 2 on the left ear, and Thalamic, Master Shoulder, Cerebral, and Lung 1 &amp; 2 on the right ear. The mother will be instructed on how to stimulate these points: she should gently apply pressure to each point for one minute, 5–6 times a day.Session 2:In addition to supportive counseling, the auriculotherapy seeds will be replaced, and the same points will be stimulated again.Session 3:During this session, the auriculotherapy seeds will once again be replaced and the same points stimulated. The counselor will also assess whether the mother has been correctly stimulating the ear points and evaluate the extent of their effectiveness.</i_keyword>
      <i_keyword>Control group: In this study, the control group will receive only the usual care after delivery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Postpartum stress. Timepoint: one and two month after delivery by controlling the effect of baseline score. Method of measurement: Perceived Stress Scale.</prim_outcome>
      <prim_outcome>Specific postpartum anxiety. Timepoint: one and two month after delivery by controlling the effect of baseline score. Method of measurement: PSAS-RSF(Postpartum Specific Anxiety Scale Research short-form).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Postpartum Depression. Timepoint: one and two month after delivery by controlling the effect of baseline score. Method of measurement: Edinburgs Postpartum Depression Scale.</sec_outcome>
      <sec_outcome>Frequency of exclusive breastfeeding. Timepoint: one and two month after delivery. Method of measurement: A checklist designed to record breastfeeding status.</sec_outcome>
      <sec_outcome>Comparison of the frequency of newborn visits by doctors. Timepoint: one and two month after delivery. Method of measurement: Checklist designed to record the number of baby visits by the doctor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-12-03</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Freedom Street, Golgasht Street, Tabriz University of Medical Sciences, Central Building No. 2, Third Floor, Research Vice-Chancellor's Office. Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
